期刊文献+

HPV16型E6蛋白诱导PHK多倍体的形成与消除细胞纺锤体检查点无关 被引量:1

HPV 16 E6 Protein Induces Polyploidy Through a Mechanism that Does Not Involve Abrogating Mitotic Spindle Checkpoints in Primary Human Keratinocytes
下载PDF
导出
摘要 目的:人乳头瘤病毒16型(human papillomavirus,HPV 16)与包括宫颈癌在内的多种肿瘤的发生明确相关。诱导宿主基因组不稳定性可能是HPV16致瘤的重要机制之一。本研究对HPV16型E6蛋白诱导人原代角质形成细胞(primary human keratinocytes,PHK)形成多倍体以及对PHK有丝分裂纺锤体检查点的影响进行初步的探索。方法:取正常人包皮组织,分离表皮,常规方法培养PHK。脂质体介导法将pBabe-16E6质粒转染逆转录病毒包装细胞PA317。挑选G418抗性克隆,检测病毒滴度,将表达HPV16型E6蛋白的高滴度逆转录病毒感染PHK。通过逆转录PCR法和免疫印迹法证实HPV16E6成功感染PHK。PHK经Nocodazole处理后,利用流式细胞仪分析多倍体形成,于不同时间点收集细胞、固定,进行抗磷酸化组蛋白染色,利用流式细胞仪分析细胞有丝分裂指数差异。结果:HPV16型E6成功感染PHK,并呈功能性表达。HPV16型E6可诱导PHK形成多倍体,表达E6蛋白的PHK和对照细胞以相似的动力学进入和退出有丝分裂。结论:HPV16型E6对PHK有丝分裂过程中的纺锤体检查点无直接影响,鉴于有丝分裂后期检查点在细胞有丝分裂过程中较持久和严格的作用,本研究结果提示,对有丝分裂后期检查点的作用可能是HPV16型E6蛋白诱导宿主细胞多倍体形成的重要机制。为进一步探讨HPV相关肿瘤的分子发生机制奠定了一定基础。 Objective: Human Papillomavirus type 16 (HPV 16) is involved in the pathogenesis of several neoplasms, including cervical cancer. Induction of genomic instability may be one of the main mechanisms in- volved in this process. The aim of this study is to investigate the impact of HPV 16 E6 on polyploidy and mitotic spindle checkpoints in primary human keratinocytes (PHK). Methods: PHK were isolated from human prepuce and cultured by routine methods. The pBabe-16 E6 vector was first transfected into the retrovirus packaging cell line PA317 using lipofectamine transduction. G418-resistant colonies were picked and assayed for virus titration. PHK were then infected with this retrovirus expressing HPV16 E6. Polyploidy was detected by flow cytometry and the mitotic index was analyzed with phospho-histone H3 staining and flow cytometry at different time points. Results: PHK were successfully infected by HPV16 E6. HPV16 E6 can induce polyploidy in PHK. PHK infected by pBabe-16 E6 or empty vector entered into mitosis with similar kinetics. Conclusion: HPV 16 E6 protein induces polyploidy through a mechanism that is not related to abrogating mitotic spindle checkpoints in PHK. These results suggest further exploration of the mechanism by which HPV oncogenes induce polyploidy in HPV-related neoplasms is needed.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2009年第1期38-41,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30572112,30600558)~~
关键词 人乳头瘤病毒 E6蛋白 原代角质形成细胞 细胞周期检查点 多倍体 Human papillomavirus E6 protein Primary keratinocyte Cell cycle checkpoint Polyploidy
  • 相关文献

参考文献12

  • 1Murga M, Femdndez--Capetillo O. Genomic instability: on the birth and death of cancer[J]. Clin Transl Oncol, 2007, 9(4): 216--220.
  • 2Duensing S, Munger K. Centrosomes, genomic instability, and cervical carcinogenesis[J]. Crit Rev Eukaryot Gene Expr, 2003, 13 (1): 9--23.
  • 3郑莹,彭芝兰,楼江燕,王和.宫颈癌及癌前病变HPV-16存在状态检测的研究[J].中国肿瘤临床,2006,33(17):961-965. 被引量:10
  • 4张三泉,曾抗,赵彤.HPV-16E6/E7在宫颈癌发生机制及疫苗中的研究进展[J].中国肿瘤临床,2004,31(16):955-957. 被引量:4
  • 5陈凌,沈柱,伍津津,张菊,周杨,范雪莉.HPV58 E6的基因克隆及HLA-DQB1*03限制性T细胞表位分析[J].细胞与分子免疫学杂志,2007,23(11):1004-1006. 被引量:2
  • 6McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF--mediated repression[J]. J Virol, 2003, 77(18): 9852-9861.
  • 7Mfinger K, Howley PM. Human papillomavirus immortalization and transformation functions[J]. Virus Res, 2002, 89(2): 213--228.
  • 8Snijders PJ, Steenbergen RD, Heideman DA, et al. HPV--mediat-- ed cervical carcinogenesis: concepts and clinical impfications[J]. J Pathol, 2006, 208(2): 152-164.
  • 9Hartwell LH, Kastan MB. Cell cycle control and cancer[J]. Science, 1994, 266(5192): 1821-1828.
  • 10Plug--Demaggio AW, McDougall JK. The human papillomavirus type 16 E6 oncogene induces premature mitotic chromosome segregation[]]. Oncogene, 2002, 21(49): 7507-7513.

二级参考文献38

  • 1夏琳,张菊,陈中灿,白玉杰,罗进,杨浩,阎小君.宫颈癌与HLA等位基因DQB1*03、DR15的相关性研究[J].第四军医大学学报,2004,25(24):2264-2266. 被引量:7
  • 2李洁,刘宝印,zur Hausen H,王宏,杨学志,李力,刘文,刘洪隐,陆克昭,刘旭,牛春燕,裴润芳,苏钟浦,王言贵,董继华,张桂宁,刘春杰,许吉林,林毓纯.中国妇女宫颈癌组织中人乳头瘤病毒感染及其地理分布的调查[J].中华实验和临床病毒学杂志,1996,10(1):50-55. 被引量:67
  • 3[1]Elenbaas B, Spirio L, Koemer F, et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells[J]. Genes Dev, 2001, 15(1):50~65
  • 4[2]Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase erpression through Myc and GC-rich SP1 binding sites[J].J Virol, 2001, 75(12):5559~5566
  • 5[3]Goodwin EC, Yang E, Lee CJ, et al. Rapid induction of senescence in human cervical carcinoma cells [J]. Proc Natl Acad Sci USA, 2000, 97(20): 10978~10983
  • 6[4]Goodwin EC, DiMaio D. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres[J]. Cell Growth Differ, 2001, 12(11):525~534
  • 7[5]Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells[J]. Nat Med, 1999, 5(10):1164~1170
  • 8[6]Veldman T, Horikawa I, Barrett Carl J, et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16E6 oncoprotein[J].J Virol, 2001, 75(9):4467~4472
  • 9[7]Baege AC, Berger A, Schlegel R, et al. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity [J].AmJ Pathol, 2002, 160(4): 1251~1257
  • 10[8]Ferber MJ, Montoya DP, Yu C, et al. Ntegrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers[J]. Oncogene, 2003, 22(24):3813~3820

共引文献13

同被引文献42

  • 1文海蓉.宫颈癌危险因素研究进展[J].疾病控制杂志,2005,9(5):452-454. 被引量:5
  • 2郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 3PARKIN D M,BRAY F,FERLAY J,et al.Estimating the world cancer burden:Globocan 2000[J].Int J Cancer,2001,94(2):153-156.
  • 4中国疾病预防控制中心.宫颈癌中国女性发病率位居第一[EB/OL].(2005-12-26)http://www.chinacdc.net.cn/n272442/n272530/n272817/n272877/10663.html.
  • 5VALDESPINO V M,VALDESPINO V E.Cervical cancer screening:state of the art[J].Curr Opin Obstet Gynecol,2006,18(1):35-40.
  • 6World Health Organization.Cytological screening in the control of cervical cancer:technical guidelines[S].Geneva:World Health Organization,1988.
  • 7MORI M,SAGAE S.Recent progress in epidemiologic research of uterine cancer[J].Gan To Kagaku Ryoho,2001,28(2):174-178.
  • 8ANTTILA A,PUKKALA F,SODERMAN B,et al.Effect of organised screening on cervical cancer incidence and mortality in Finland,1963-1995:recent increase in cervical cancer incidence[J].Int J Cancer,1999,83(1):59-65.
  • 9GALANI E,CHRISTODOULOU C.Human papilloma viruses and cancer in the post-vaccine era[J].Clin Microbiol Infect,2009,15(11):977-981.
  • 10CLIFFORD G M,SMITH J S,PLUMMER M,et al.Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[J].Br J Cancer,2003,88(1):63-73.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部